The novel therapy of the medication represents a major development in the handling of diabetes mellitus type 2. Distinct from existing drugs, tirzepatide targets two pathways – GLP-1 and the GIP hormone – leading https://tirzepatide-peptide049843.fare-blog.com/42489341/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment